Staphylococcal Infections — V710 First-In-Man (FIM) Study (V710-001)
Citation(s)
A Sequential-Panel, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine in Healthy Adults 18 to 55 Years of Age